Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Lenalidomide may stop the growth of kidney cancer by blocking blood flow to the
tumor.
PURPOSE: This phase II trial is studying how well lenalidomide works in treating patients
with advanced or unresectable kidney cancer.